Title: Cost-effectiveness Analysis on Lmport and Domestic Entecavir for Therapy of Chronic Hepatitis b
Abstract: Objective: To compare cost-effectiveness import and domestic entecavir for therapy of chronic hepatitis B. Method: 50 cases of chronic hepatitis B patients were selected,they were randomly divided into study 1 group and study 2 group,each group with 25 cases. Study 1 group were given domestic entecavir dispersible tablet; Study 2 group were given imported entecavir tablets. Result: The total effective rate of Study 1 group and Study 2 group was 64.0% and 68.0%; the treatment cost was respectively 2788.8 yuan and 5712 yuan; cost-effectiveness ratio( C / E) was 43.6 and 84.Conclusion: Domestic and imported entecavir have significant effect on chronic hepatitis B,and domestic entercavir lower cost in treatment,It's worthy of clinical application.
Publication Year: 2014
Publication Date: 2014-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot